| 3.64 -0.11 (-2.93%) | 05-13 13:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.66 | 1-year : | 5.44 |
| Resists | First : | 3.99 | Second : | 4.66 |
| Pivot price | 3.55 |
|||
| Supports | First : | 3.37 | Second : | 3 |
| MAs | MA(5) : | 3.71 |
MA(20) : | 3.54  |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 58.3 |
D(3) : | 58.4 |
| RSI | RSI(14): 53.6 |
|||
| 52-week | High : | 7.26 | Low : | 3 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ PLSM ] has closed below upper band by 18.4%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 3.77 - 3.79 | 3.79 - 3.8 |
| Low: | 3.56 - 3.58 | 3.58 - 3.6 |
| Close: | 3.62 - 3.65 | 3.65 - 3.68 |
Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe. The company offers Pulsenmore home ultrasound system, a handheld ultrasound cradle dock with the patient's smartphone; mobile app for uploading images to the cloud for review; and clinician dashboard for clinician to review a stored video or guide a scan in real-time. The company was incorporated in 2014 and is based in Omer, Israel.
Thu, 09 Apr 2026
Does inflation impact Pulsenmore (PLSM) Stock | Price at $3.35, Down 2.05% - Stock Screening - UBND thành phố Hải Phòng
Thu, 02 Apr 2026
What does insider activity suggest for Pulsenmore (PLSM) Stock | Price at $3.34, Down 5.92% - Elite Trading Signals - newser.com
Wed, 21 Jan 2026
Pulsenmore To Commence Trading on Nasdaq as It Expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S. - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 7 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 43.4 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 1 (K) |
| Shares Short P.Month | 1 (K) |
| EPS | -0.83 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | -39.7 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -6.3 % |
| Return on Equity (ttm) | -17.7 % |
| Qtrly Rev. Growth | 578.2 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -1.59 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 8 (M) |
| PE Ratio | -4.52 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|